Evidence map›Paper›PMID 26304890›Full record

ArticleJournal of clinical oncology : official journal of the American Society of Clinical Oncology2015

Reply to G. Keramida et al.

Sally F Barrington, N George Mikhaeel, Lale Kostakoglu, Michel Meignan, Martin Hutchings, Stefan Müeller, Lawrence H Schwartz, Emanuele Zucca, Richard I Fisher, Judith Trotman and 6 more

Abstract readLetterComment
PubMed Publisher
In one paragraph

Article in Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

16 authors.

Sally F BarringtonKing's College London, London, United Kingdom sally.barrington@kcl.ac.uk.
N George MikhaeelGuy's and St Thomas' National Health Service Foundation Trust, London, United Kingdom.
Lale KostakogluMount Sinai Medical Center, New York, NY.
Michel MeignanCentre Universitaire Hospitalier Henri Mondor, Paris, France.
Martin HutchingsCopenhagen University Hospital, Copenhagen, Denmark.
Stefan MüellerUniversitätsklinikum Essen, Essen, Germany.
Lawrence H SchwartzColumbia University Medical Center, New York, NY.
Emanuele ZuccaOncology Institute of Southern Switzerland, Bellinzona, Switzerland.
Richard I FisherFox Chase Cancer Center, Philadelphia, PA.
Judith TrotmanConcort Hospital and University of Sydney, Sydney, New South Wales, Australia.
Otto S HoekstraVrije Universiteit Medical Centre, Amsterdam, the Netherlands.
Rodney J HicksPeter MacCallum Cancer Centre and University of Melbourne, Melbourne, Victoria, Australia.
Michael J O'DohertyKing's College London, London, United Kingdom.
Roland HustinxUniversity of Liège, Liège, Belgium.
Alberto BiggiAzienda Ospedaliera S. Croce e Carle, Cuneo, Italy.
Bruce D ChesonGeorgetown University Hospital, Washington, DC.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Fluorodeoxyglucose F18Positron-Emission TomographyRadiopharmaceuticalsTomography, X-Ray ComputedHumansLymphomaFluorodeoxyglucose F18Radiopharmaceuticals

Identifiers

PMID26304890

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.